New Page 1

Books

1.) AAP 1997 Red Book: report of the Committee on Infectious Disease. 24^th edition. New York: American Academy of Pediatrics, 1997.

2.) Ada, Gordon. and Ramsay, Alistair. Vaccines, Vaccination and the Immune Response. Philadelphia: Lippincott-Raven Publishers, 1997.

3.) Bennett. Cecil Textbook of Medicine. 20^th edition. W. B. Saunders Company, 1996.

4.) Fields, Bernard N., ed. Fields Virology 3^rd edition. Philadelphia: Lippincott-Raven Publishers, 1996. 1: 1177-1313, 899-931.

5.) Ishii, Keizo. and Nakazono, Naoki. Epidemiology of Rubella and its Prevention. Saporo: Kokoku Co., 1984.

6.) Kuby, Janis. Immunology. 3^rd edition. New York: W. H. Freeman and Company, 1997.

7.) Plotkin, Stanley A. and Orenstein, Walter. A. Vaccines. 3^rd edition. Philadelphia: W.B. Saunders Company, 1998. 222-293, 409-441 and 508-531.

8.)Smith, Kenneth and Markham, Roy. Mumps, Measles and Mosaics: A Study of Animal and Plant Viruses. London: Collins Clear-Type Press, 1954. 56-58.

9.) State of the worldís vaccines and immunization. Switzerland: World Health Organization, 1996. 39-44, 86-89.

Articles

10.) Bautista-López, Norma, et. al. ìDevelopment and durability of measles antigen-specific lymphoproliferative response after MMR vaccination.î Vaccine. 2000, 18: 1393-1401.

11.) Belloni, C. et al. ìRevaccination against hepatitis B virus of non-responding and low-responding infants immunized at birth.A parallel evaluation of rubella and tetanus vaccine.î Vaccine. 16: 399-402.

12.) Davidkin, Irja, et. al. ìEtiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children.î The Journal of Infectious Diseases. 1998, 178: 1567-1570.

13.) Davidkin, Irja and Valle, Martti. ìVaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts.î Vaccine. Great Britain: Elsevier Science Ltd. 1998, 16: 2052-2057.

14.) De Serres, Gaston, et. al. ìProtection after two doeses of measles vaccine is independent of interval between doses.î The Journal of Infectious Diseases. 1999, 180: 187-190.

15.) Fennelly, Glenn J. et. al. ìMucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector.î The Journal of Immunology. 1998, 162: 1603-1610.

16.) FitzSimons, D.W. and Van Damme, P. ìEuropean forum on immunization: report of Second General Meeting, Munich, 2-3 June 1997.î European Journal of Pediatrics. 1999, 158: 359-361.

17.) Gans, Hayley A. et al. ìIL-12, IFN-g, and T cell proliferation to measles in immunized infants.î Journal of Immunology. 1999, 162: 5569-5575.

18.) Gold, Eli. ìAlmost extinct diseases: Measles, mumps, rubella, and pertussis.î Pediatrics in Review. American Academy of Pediatrics. 1996, 17: 120-125.

19.) Mitchell, Leslie Ann, et. al. ìIdentification of rubella virus T-cell epitopes recognized in anamnestic response to RA27/3 vaccine: associations with boost in neutralizing antibody titer.î Vaccine. 1999, 17: 2356-2365.

20.) Ogata, Akihiko, et. al. ìAbsense of measles virus receptor (CD46) in lesions of subacute sclerosing panencephalitis brains.î Acta Neuropathol. 1994, 94: 444-449.

21.) Rhodes, Christopher J. and Butler, A.R. ìEpidemiology of communicable disease in small populations.î Journal of Molecular Medicine. 1998, 76: 111-116.

22.) Schwarzer, Simone, et. al. ìSafety and characterization of the immune resonse engendered by two combined measles, mumps, and rubella vaccines.î Vaccine. 1997, 16: 298-304.

23.) Soilu-Hänninen, Merja, et al. ìMeasles virus hemagglutinin mediates monocyte aggregation and increased adherence to measles-infected endothelial cells.î Medical Microbiology of Immunology. Spring-Verlag 1996, 185: 73-80.

24.) Sollu-Hänninen, et. al. ìMeasles virus hemagglutinin mediates monocyte aggregation and increased adherence to measles infected endothelial cells.î Med Microbio Immunol. 1996, 185: 73-80.

25.) Toyoda, Mika, et. al. ìExpression of interleukin-2 receptor a and CD45RO antigen on T lymphocytes cultured with rubella virus antigen, compared with humoral immunity in rubella vaccinees.î Vaccine. 1999, 17: 2051-2058.

26.) U.S. Preventive Services Task Force, Guidelines from Guide to Clinical Preventive Services 2^nd Edition. 1996.

Back to Top

Websites

27.) www.tulane.edu/~dmsander/Big_Virology/BVRNApara.html

28.) www.immunize.org/images/ca.d/ipcd1861/img0017.htm

29.) www.immunize.org/catg.d/pict001.htm

30.) www.immunize.org/images/ca.d/ipcd1861/img0018.htm

Home

Books

1.) AAP 1997 Red Book: report of the Committee on Infectious Disease. 24th edition. New York: American Academy of Pediatrics, 1997.

2.) Ada, Gordon. and Ramsay, Alistair. Vaccines, Vaccination and the Immune Response. Philadelphia: Lippincott-Raven Publishers, 1997.

3.) Bennett. Cecil Textbook of Medicine. 20th edition. W. B. Saunders Company, 1996.

4.) Fields, Bernard N., ed. Fields Virology 3rd edition. Philadelphia: Lippincott-Raven Publishers, 1996. 1: 1177-1313, 899-931.

5.) Ishii, Keizo. and Nakazono, Naoki. Epidemiology of Rubella and its Prevention. Saporo: Kokoku Co., 1984.

6.) Kuby, Janis. Immunology. 3rd edition. New York: W. H. Freeman and Company, 1997.

7.) Plotkin, Stanley A. and Orenstein, Walter. A. Vaccines. 3rd edition. Philadelphia: W.B. Saunders Company, 1998. 222-293, 409-441 and 508-531.

8.)Smith, Kenneth and Markham, Roy. Mumps, Measles and Mosaics: A Study of Animal and Plant Viruses. London: Collins Clear-Type Press, 1954. 56-58.

9.) State of the worldís vaccines and immunization. Switzerland: World Health Organization, 1996. 39-44, 86-89.

Back to Top

Articles

12.) Davidkin, Irja, et. al. ìEtiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children.î The Journal of Infectious Diseases. 1998, 178: 1567-1570.

13.) Davidkin, Irja and Valle, Martti. ìVaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts.î Vaccine. Great Britain: Elsevier Science Ltd. 1998, 16: 2052-2057.

16.) FitzSimons, D.W. and Van Damme, P. ìEuropean forum on immunization: report of Second General Meeting, Munich, 2-3 June 1997.î European Journal of Pediatrics. 1999, 158: 359-361.

17.) Gans, Hayley A. et al. ìIL-12, IFN-g, and T cell proliferation to measles in immunized infants.î Journal of Immunology. 1999, 162: 5569-5575.

18.) Gold, Eli. ìAlmost extinct diseases: Measles, mumps, rubella, and pertussis.î Pediatrics in Review. American Academy of Pediatrics. 1996, 17: 120-125.

21.) Rhodes, Christopher J. and Butler, A.R. ìEpidemiology of communicable disease in small populations.î Journal of Molecular Medicine. 1998, 76: 111-116.

23.) Soilu-Hänninen, Merja, et al. ìMeasles virus hemagglutinin mediates monocyte aggregation and increased adherence to measles-infected endothelial cells.î Medical Microbiology of Immunology. Spring-Verlag 1996, 185: 73-80.

26.) U.S. Preventive Services Task Force, Guidelines from Guide to Clinical Preventive Services 2nd Edition. 1996.

Back to Top

1.) AAP 1997 Red Book: report of the Committee on Infectious Disease. 24^th edition. New York: American Academy of Pediatrics, 1997.

3.) Bennett. Cecil Textbook of Medicine. 20^th edition. W. B. Saunders Company, 1996.

4.) Fields, Bernard N., ed. Fields Virology 3^rd edition. Philadelphia: Lippincott-Raven Publishers, 1996. 1: 1177-1313, 899-931.

6.) Kuby, Janis. Immunology. 3^rd edition. New York: W. H. Freeman and Company, 1997.

7.) Plotkin, Stanley A. and Orenstein, Walter. A. Vaccines. 3^rd edition. Philadelphia: W.B. Saunders Company, 1998. 222-293, 409-441 and 508-531.

26.) U.S. Preventive Services Task Force, Guidelines from Guide to Clinical Preventive Services 2^nd Edition. 1996.